Efficacy of Surgery and Further Treatment of Progressive Glioblastoma

World Neurosurgery

Volumn 84, Issue 2, 2015, Pages 301-307

  Woernle, Christoph Michael ^a   Péus, Dominik ^a   Hofer, Silvia ^a   Rushing, Elisabeth Jane ^a   Held, Ulrike ^a   Bozinov, Oliver ^a   Krayenbühl, Niklaus ^a   Weller, Michael ^b   Regli, Luca ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bevacizumab; Glioblastoma; Neurosurgery; Prognostic score; Recurrence; Temozolomide

Indexed keywords

ALKYLATING AGENT; BEVACIZUMAB; LOMUSTINE; TEMOZOLOMIDE;

ADULT; AGE; ARTICLE; BRAIN REGION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DECISION MAKING; DISEASE COURSE; FEMALE; FUNCTIONAL STATUS; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; OVERALL SURVIVAL; POSTOPERATIVE CARE; RATING SCALE; RECURRENT GLIOBLASTOMA SCALE; REOPERATION; AGED; BRAIN NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

AGE FACTORS; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84938979127     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2015.03.018     Document Type: Article

References (26)

1. M. Ammirati, J.H. Galicich, E. Arbit, and Y. Liao Reoperation in the treatment of recurrent intracranial malignant gliomas Neurosurgery 21 1987 607 614
2. G.M. Barbagallo, M.D. Jenkinson, and A.R. Brodbelt 'Recurrent' glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22 2008 452 455
3. F.G. Barker, S.M. Chang, P.H. Gutin, M.K. Malec, M.W. McDermott, M.D. Prados, and C.B. Wilson Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 1998 709 720 discussion 20-23
4. O. Bloch, S.J. Han, S. Cha, M.Z. Sun, M.K. Aghi, M.W. McDermott, M.S. Berger, and A.T. Parsa Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article J Neurosurg 117 2012 1032 1038
5. K.A. Carson, S.A. Grossman, J.D. Fisher, and E.G. Shaw Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials J Clin Oncol 25 2007 2601 2606
6. K.L. Chaichana, P. Zadnik, J.D. Weingart, A. Olivi, G.L. Gallia, J. Blakeley, M. Lim, H. Brem, and A. Quinones-Hinojosa Multiple resections for patients with glioblastoma: prolonging survival J Neurosurg 118 2013 812 820
7. J.L. Clarke, M.M. Ennis, W.K. Yung, S.M. Chang, P.Y. Wen, T.F. Cloughesy, L.M. Deangelis, H.I. Robins, F.S. Lieberman, H.A. Fine, L. Abrey, M.R. Gilbert, M. Mehta, J.G. Kuhn, K.D. Aldape, K.R. Lamborn, and M.D. Prados Consortium North American Brain Tumor: Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol 13 2011 1118 1124
8. S.E. Combs, L. Edler, R. Rausch, T. Welzel, W. Wick, and J. Debus Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma Acta Oncol 52 2013 147 152
9. P. Dirks, M. Bernstein, P.J. Muller, and W.S. Tucker The value of reoperation for recurrent glioblastoma Can J Surg 36 1993 271 275
10. J. Fink, D. Born, and M.C. Chamberlain Pseudoprogression: relevance with respect to treatment of high-grade gliomas Curr Treat Options Oncol 12 2011 240 252
11. G.R. Harsh, V.A. Levin, P.H. Gutin, M. Seager, P. Silver, and C.B. Wilson Reoperation for recurrent glioblastoma and anaplastic astrocytoma Neurosurgery 21 1987 615 621
12. R. Helseth, E. Helseth, T.B. Johannesen, C.W. Langberg, K. Lote, P. Ronning, D. Scheie, A. Vik, and T.R. Meling Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme Acta Neurol Scand 122 2010 159 167
13. M. Holdhoff, and M.C. Chamberlain Controversies in the treatment of elderly patients with newly diagnosed glioblastoma J Natl Compr Canc Netw 11 2013 1165 1172 quiz 73
14. D.R. Johnson, and B.P. O'Neill Glioblastoma survival in the United States before and during the temozolomide era J Neurooncol 107 2012 359 364
15. T.N. Kreisl, L. Kim, K. Moore, P. Duic, C. Royce, I. Stroud, N. Garren, M. Mackey, J.A. Butman, K. Camphausen, J. Park, P.S. Albert, and H.A. Fine Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clini Oncol 27 2009 740 745
16. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
17. C. Nieder, A.L. Grosu, and M. Molls A comparison of treatment results for recurrent malignant gliomas Cancer Treat Rev 26 2000 397 409
18. C.K. Park, J.H. Kim, D.H. Nam, C.Y. Kim, S.B. Chung, Y.H. Kim, H.J. Seol, T.M. Kim, S.H. Choi, S.H. Lee, D.S. Heo, I.H. Kim, D.G. Kim, and H.W. Jung A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma Neuro Oncol 15 2013 1096 1101
19. J.K. Park, T. Hodges, L. Arko, M. Shen, D. Dello Iacono, A. McNabb, N.O. Bailey, T. Nguyen Kreisl, F.M. Iwamoto, J. Sul, S. Auh, G.E. Park, H.A. Fine, and P. McL Black Scale to predict survival after surgery for recurrent glioblastoma multiforme J Clin Oncol 28 2010 3838 3843
20. W. Roa, P.M. Brasher, G. Bauman, M. Anthes, E. Bruera, A. Chan, B. Fisher, D. Fulton, S. Gulavita, C. Hao, S. Husain, A. Murtha, K. Petruk, D. Stewart, P. Tai, R. Urtasun, J.G. Cairncross, and P. Forsyth Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
21. N. Sanai, and M.S. Berger Glioma extent of resection and its impact on patient outcome Neurosurgery 62 2008 753 764 discussion 264-266
22. A.M. Stark, A. Nabavi, H.M. Mehdorn, and U. Blomer Glioblastoma multiforme - report of 267 cases treated at a single institution Surg Neurol 63 2005 162 169 discussion 69
23. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Research European Organisation for Tumor Treatment of Cancer Brain, Group Radiotherapy, and Group National Cancer Institute of Canada Clinical Trials: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
24. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J.B. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A.A. Brandes, J. Gijtenbeek, C. Marosi, C.J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Gregory Cairncross, and R.O. Mirimanoff Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EOTC-NCIC trial Lancet Oncol 10 2009 459 466
25. M. Weller, T. Cloughesy, J.R. Perry, and W. Wick Standards of care for treatment of recurrent glioblastoma - are we there yet? Neuro Oncol 15 2013 4 27
26. P.O. Zinn, P. Sathyan, B. Mahajan, J. Bruyere, M. Hegi, S. Majumder, and R.R. Colen A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microrna-gene signature PLoS One 7 2012 e41522